Advertisement

Topics

Search Results for "Brilinta Sales"

04:36 EDT 24th August 2016 | BioPortfolio

Matching Channels

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Sales Jobs

OxyContin

OxyContin, an narcotic <!--LGfEGNT2Lhm-->analgesic produced by Purdue Pharma LP, nets $3m in <!--LGfEGNT2Lhm-->sales annually, placing it 8th in the world for annual sales. OxyContin i...

GE Healthcare

Ranked as the third largest medical device company in the world (based on annual sales), GE Healthcare generates $16 billion in sales each year. GEs' area of expertise is the imaging that is i...

Siemens

Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...

Matching News

Brilinta preferred over clopidogrel in new guideline for heart attack patients

Anglo-Swedish pharma major AstraZeneca has welcomed a new treatment guideline which recommends its Brilinta…

Brilinta No Better Than Aspirin In Stroke Trial

Topline data from the SOCRATES trial of Brilinta (Brilique; ticagrelor) provided more ammunition for those pushing for AstraZeneca's CEO Pascal Soriot to have his pay linked to performance.

BRIEF-Astrazeneca says Brilinta Socrates study misses main goal

* Astrazeneca reports top-line results from Brilinta Socrates trial in stroke

BRIEF-AstraZeneca says ACC, AHA guidelines prefer Brilinta over clopidogrel

* Brilinta preferred over clopidogrel in updated American College of Cardiology, American Heart Association guideline in acute coronary syndrome Source text : http://bit.ly/25xRutZ Further company cov...

Rückschlag für Astrazeneca beim Hoffnungsträger Brilinta

Von Denise Roland LONDON (Dow Jones)--Der Pharmakonzern Astrazeneca hat bei einem seiner Hoffnungsträger ein enttäuschendes Studienergebnis verzeichnet. Der Blutverdünner Brilinta ist beim Einsatz....

AstraZeneca's heart drug Brilinta fails in stroke trial

AstraZeneca said its Brilinta heart drug has failed to show a significant benefit in patients suffering with acute ischaemic stroke.

FDA: Brintellix changing name to avoid confusion with brilinta

(HealthDay)—Following a July 2015 Drug Safety Communication that warned about name confusion between Brintellix and Brilinta resulting in prescribing errors, the antidepressant Brintellix (vortioxet...

AZ's key drug Brilique fails in stroke trial

AstraZeneca's Brilinta/Brilique (ticagrelor) has failed to improve on aspirin in a cardiovascular event trial, according to top line results announced today. The news will put a dent in AZ's hopes for...

Matching PubMed Articles

Property of Fluctuations of Sales Quantities by Product Category in Convenience Stores.

The ability to ascertain the extent of product sale fluctuations for each store and locality is indispensable to inventory management. This study analyzed POS data from 158 convenience stores in Kawas...

Tracking Cholera through Surveillance of Oral Rehydration Solution Sales at Pharmacies: Insights from Urban Bangladesh.

In Bangladesh, pharmacy-purchased oral rehydration solution (ORS) is often used to treat diarrhea, including cholera. Over-the-counter sales have been used for epidemiologic surveillance in the past, ...

Iodisation of Salt in Slovenia: Increased Availability of Non-Iodised Salt in the Food Supply.

Salt iodisation is considered a key public health measure for assuring adequate iodine intake in iodine-deficient countries. In Slovenia, the iodisation of all salt was made mandatory in 1953. A consi...

Estimation of the unregistered inflow of electrical and electronic equipment to a domestic market: a case study on televisions in Vietnam.

Waste electrical and electronic equipment (WEEE) constitutes one of the most problematic waste streams worldwide, and accurately estimating the scale of WEEE can assist in tackling its associated issu...

Raising the Legal Age of Tobacco Sales: Policy Support and Trust in Government, 2014-2015, U.S.

The National Academy of Medicine has called for an increase in the minimum age of tobacco product sales. It is not clear what age increase would garner the greatest public support, or whether trust in...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement